12 unchanged sentences
A description of our critical accounting policies is provided in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended March 31, 2024.
−Removed: As of September 30, 2024, our critical accounting policies and estimates continued to include investment valuation, inventory valuation, and deferred tax assets estimation.
−Removed: Quarter ended September 30, 2024, compared to quarter ended September 30, 2023
+Added: As of December 31, 2024, our critical accounting policies and estimates continued to include investment valuation, inventory valuation, and deferred tax assets estimation.
+Added: Quarter ended December 31, 2024, compared to quarter ended December 31, 2023
The table shown below summarizes the percentage of revenue and quarter-to-quarter changes for various items:
Percentage of Revenue
−Removed: Quarter Ended September 30,
+Added: Quarter Ended December 31,
Product sales
4 unchanged sentences
Selling, general, and administrative
−Removed: Provision for (recovery of) credit losses
Total expenses
3 unchanged sentences
Provision for income taxes
−Removed: Total revenue for the quarter ended September 30, 2024 (the second quarter of fiscal 2025) decreased 5% compared to the quarter ended September 30, 2023 (the second quarter of fiscal 2024).
−Removed: The decrease was due to a 14% decrease in product sales, partially offset by a 3,950% increase in contract research and development revenue.
+Added: Total revenue for the quarter ended December 31, 2024 (the third quarter of fiscal 2025) decreased 25% compared to the quarter ended December 31, 2023 (the third quarter of fiscal 2024).
+Added: The decrease was due to a 22% decrease in product sales and a 74% decrease in contract research and development revenue.
The decrease in product sales was due to decreased purchases by existing customers.
−Removed: The increase in contract research and development revenue was due to a major research and development contract completed during the quarter ended September 30, 2024.
−Removed: Gross margin percentage for the second quarter of fiscal 2025 was 86%, compared to 78% the prior-year quarter.
+Added: The decrease in contract research and development revenue was due to the completion of certain contracts.
+Added: Gross margin for the third quarter of fiscal 2025 was 84% of revenue, compared to 80% the prior-year quarter.
The increase in gross margin percentage was due to a more profitable product mix and a larger portion of direct rather than distributor sales.
−Removed: Total expenses increased 55% for the second quarter of fiscal 2025 compared to the second quarter of fiscal 2024 due to a 24% increase in research and development expense, a 31% increase in selling, general, and administrative expense and a $202,926 recovery of credit losses in the prior-year quarter.
+Added: Total expenses increased 40% for the third quarter of fiscal 2025 compared to the third quarter of fiscal 2024 due to a 61% increase in research and development expense and a 12% increase in selling, general, and administrative expense.
The increase in research and development expense was due to increased new product development activities.
The increase in selling, general, and administrative expenses was primarily due to increased sales and marketing activities.
−Removed: Interest income for the second quarter of fiscal 2025 decreased 9% due to lower yields on recently purchased marketable securities.
−Removed: Our effective tax rate, which is the provision for income taxes as a percentage of income before taxes, increased to 17% for the second quarter of fiscal 2025 compared to 8% for the second quarter of fiscal 2024.
−Removed: The lower tax rate for the prior-year quarter was due to a $202,926 credit loss recovery and changes in the timing and amounts of federal tax credits and deductions.
−Removed: The 15% decrease in net income in the second quarter of fiscal 2025 compared to the prior-year quarter was primarily due to decreased revenue, increased operating expenses, decreased interest income, and a higher effective tax rate, partially offset by increased gross profit margin.
−Removed: Six months ended September 30, 2024, compared to six months ended September 30, 2023
+Added: Interest income for the third quarter of fiscal 2025 decreased 4% due to a decrease in marketable securities and lower yields on recently purchased marketable securities.
+Added: Other income in the third quarter of fiscal 2025 was primarily from the reclaiming of precious metals used in our manufacturing process.
+Added: Our effective tax rate, which is the provision for income taxes as a percentage of income before taxes, decreased to 15% for the third quarter of fiscal 2025 compared to 16% for the third quarter of fiscal 2024.
+Added: The decrease in our effective tax rate compared to the prior-year quarter was due changes in the timing and amounts of federal tax credits and deductions.
+Added: The 27% decrease in net income in the third quarter of fiscal 2025 compared to the prior-year quarter was primarily due to decreased revenue, increased operating expenses, and decreased interest income, partially offset by increased gross profit margin, increased other income, and a lower effective tax rate.
+Added: Nine months ended December 31, 2024, compared to nine months ended December 31, 2023
The table shown below summarizes the percentage of revenue and period-to-period changes for various items:
Percentage of Revenue
−Removed: Six Months Ended Sept.
+Added: Nine Months Ended Dec.
Product sales
10 unchanged sentences
Provision for income taxes
−Removed: Total revenue for the six months ended September 30, 2024, decreased 15% compared to the six months ended September 30, 2023.
−Removed: The decrease was due to a 20% decrease in product sales, partially offset by and a 457% increase in contract research and development revenue.
+Added: Total revenue for the nine months ended December 31, 2024, decreased 18% compared to the nine months ended December 31, 2023.
+Added: The decrease was due to a 20% decrease in product sales, partially offset by a 72% increase in contract research and development revenue.
The decrease in product sales was due to decreased purchases by existing customers.
−Removed: The increase in contract research and development revenue was due to a major research and development contract completed during the quarter ended September 30, 2024.
−Removed: Gross margin percentage for the first six months of fiscal 2025 was 86%, compared to 77% for the first six months of fiscal 2024.
+Added: The increase in contract research and development revenue was due to a major research and development contract completed during the nine months ended December 31, 2024.
+Added: Gross margin for the first nine months of fiscal 2025 was 85% of revenue, compared to 78% for the first nine months of fiscal 2024.
The increase in gross margin percentage was due to a more profitable product mix and a larger portion of direct rather than distributor sales.
−Removed: Total expenses increased 23% for the first six months of fiscal 2025 compared to the first six months of fiscal 2024 due to a 25% increase in research and development expense and a 22% increase in selling, general, and administrative expense.
+Added: Total expenses increased 28% for the first nine months of fiscal 2025 compared to the first nine months of fiscal 2024 due to a 35% increase in research and development expense and a 19% increase in selling, general, and administrative expense.
The increase in research and development expense was due to increased new product development activities.
The increase in selling, general, and administrative expenses was primarily due to increased sales and marketing activities.
−Removed: The 11% decrease in net income for the first six months of fiscal 2025 compared to the prior-year period was primarily due to decreased revenue and increased expenses, partially offset by increased interest income and increased gross profit margin.
+Added: The 16% decrease in net income for the first nine months of fiscal 2025 compared to the prior-year period was primarily due to decreased revenue, increased operating expenses, and decreased interest income, partially offset by increased other income and increased gross profit margin.
Liquidity and Capital Resources
−Removed: Cash and cash equivalents were $3,096,179 as of September 30, 2024, compared to $10,283,550 as of March 31, 2024.
−Removed: The $7,187,371 decrease in cash and cash equivalents during the first half of fiscal 2025 was due to $5,505,577 of cash used in investing activities and $9,667,381 of net cash used in financing activities, partially offset by $7,985,587 in net cash provided by operating activities.
+Added: Cash and cash equivalents were $5,485,684 as of December 31, 2024, compared to $10,283,550 as of March 31, 2024.
+Added: The $4,797,866 decrease in cash and cash equivalents during the first nine months of fiscal 2025 was due to $2,237,563 of cash used in investing activities and $14,388,356 of net cash used in financing activities, partially offset by $11,828,053 in net cash provided by operating activities.
Operating Activities
Net cash provided by operating activities related to product sales and research and development contract revenue was our primary source of working capital for the current and prior-year quarters.
−Removed: Accounts receivable decreased $192,402 during the first six months of fiscal 2025 primarily due to decreased revenue and the timing of customer payments.
−Removed: Inventories increased $259,026 primarily due to our decision to increase raw material and finished goods inventories in anticipation of a semiconductor industry recovery.
−Removed: Prepaid expenses and other assets decreased $156,116 primarily due to decreased bond interest receivable and prepayments for raw materials.
−Removed: Accounts payable and accrued expenses decreased $106,018 primarily due to decreased accrual for performance-based compensation.
+Added: Accounts receivable decreased $1,789,769 during the first nine months of fiscal 2025 primarily due to decreased revenue and the timing of customer payments.
+Added: Inventories increased $629,039 primarily due to our decision to increase inventories in anticipation of a semiconductor industry recovery.
+Added: Prepaid expenses and other assets increased $47,132 primarily due to the timing of federal estimated tax payments.
+Added: Accrued payroll and other expenses decreased $217,626 primarily due to decreased accrual for performance-based compensation.
Investing Activities
−Removed: Cash used by investing activities during the six months ended September 30, 2024, consisted of $6,580,140 of marketable securities purchases and $1,125,437 of fixed asset purchases, partially offset by $2,200,000 in proceeds from maturities of marketable securities.
−Removed: Fixed asset purchases consisted of a $1,125,437 downpayment on production equipment expected to be delivered in fiscal 2026.
+Added: Cash used by investing activities during the nine months ended December 31, 2024, consisted of $11,279,773 of marketable securities purchases and $1,162,790 of fixed asset purchases, partially offset by $10,205,000 in proceeds from maturities of marketable securities.
+Added: Fixed asset purchases consisted primarily of a $1,125,437 downpayment on production equipment expected to be delivered in fiscal 2026.
We plan to significantly increase fixed asset purchases in fiscal 2025 and 2026 compared to fiscal 2024 to support increases in production capacity and new product development.
Financing Activities
−Removed: Cash used in financing activities during the six months ended September 30, 2024, primarily consisted of $9,667,352 of cash dividends paid to shareholders.
−Removed: In addition to cash dividends to shareholders paid in the first quarter of fiscal 2025, on October 23, 2024, we announced that our Board of Directors had declared a cash dividend of $1.00 per share of Common Stock, or $4,834,020 based on shares outstanding as of September 30, 2024, to be paid on November 29, 2024.
+Added: Cash used in financing activities during the nine months ended December 31, 2024, consisted of $14,502,518 of cash dividends paid to shareholders, partially offset by $114,162 in proceeds from stock option exercises.
+Added: In addition to cash dividends to shareholders paid in the first quarter of fiscal 2025, on January 22, 2025, we announced that our Board of Directors had declared a cash dividend of $1.00 per share of Common Stock, or $4,837,166 based on shares outstanding as of December 31, 2024, to be paid on February 28, 2025.
We plan to fund dividends through cash provided by operating activities and proceeds from maturities of marketable securities.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.